Medical Device Maker Highlights China Risk as Chinese U.S. IPOs Resume
Meihua International’s updated prospectus includes new section on Beijing’s intent to ‘exert more oversight and control’ over overseas Chinese listings Key Takeaways: Meihua International files updated prospectus highlighting China oversight…
RELATED ARTICLES
-
Atour glides as economic slowdown fails to dent Chinese travel demand
ATAT.US
-
Atour shines on tourism rebound, but ‘revenge travel’ likely to be fleeting
ATAT.US
- CHINA BULLETIN: China Pumps Up Economy with Cash, But Nobody’s Borrowing
- China reaffirms support for offshore IPOs, but new listings likely to remain small
- Delonix’s new Marriott tie-up hints at re-listing attempt post-pandemic
- China-U.S. IPOs take big step toward resumption with Cheche listing
- China-U.S. IPO train creeps ahead with first new listing application
Discover hidden China stock gems in our weekly newsletter